Belharra Therapeutics is a privately held drug discovery company that is disrupting the drug discovery paradigm with its novel photoaffinity-based chemoproteomics platform. Belharra scientists can identify small molecule drug candidates for any binding site, on any protein, in any conformational state, and in any cell type using its chemoproteomicsplatform. Belharra is based in the San Francisco Bay Area, with its primary lab and offices in San Diego.

Biotechnology

Therapeutics

Belharra Therapeutics

Jeff Jonker

Lisa Allen

Olesya Ulanovskaya

Jessica Alexander

Kelly Chow

Sherry Niessen

Justin Ernst

Sean Buchanan

Sharon Tetlow

Rachel Lane

Gary O’Neill

The Research and Development team at Belharra Therapeutics leverages a cutting-edge photoaffinity-based chemoproteomics platform to identify and develop small molecule drug candidates. This team spans various disciplines including medicinal and discovery chemistry, discovery biology, and bioinformatics, working collaboratively to discover new drugs for diverse protein targets in different cellular contexts. The team includes senior scientists, associate scientists, and research associates who drive innovative research that advances the company's drug discovery initiatives.

Research and Development

Leadership Team

Operations

Research and Development

About

Team members

Other teams at Belharra Therapeutics

Leadership Team

Operations